查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1291493

2023-2028年按劑量、應用、終端用戶和地區分類的腎上腺素自動注射器市場

Epinephrine Autoinjector Market by Dosage, Application, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

市場概況：

2022年，全球腎上腺素自動注射器市場規模達到22億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到34億美元，在2023-2028年期間表現出9.40%的成長率（CAGR）。過敏症患者人數的增加，自我管理藥物的需求上升，以及智慧腎上腺素自動注射器的推出，代表了推動市場的一些關鍵因素。

腎上腺素自動注射器是一種醫療設備，用於輕鬆注射單劑量的腎上腺素，以治療由蜇傷、蟲咬或藥物引起的嚴重過敏反應。它被設計為將藥物注射到個人的大腿肌肉中，通過收縮血管和擴張呼吸道發揮作用，以盡量減少過敏反應的症狀。它體積小，便於攜帶，可由個人或醫護人員施用。目前，領先的製造商正在推出腎上腺素自動注射器，它具有多劑量的藥物和可調整的劑量，使用戶能夠根據過敏反應的嚴重程度調整劑量，提高治療的有效性。它們還結合了音頻和視覺說明，使個人在緊急情況下更容易使用它們。

腎上腺素自動注射器市場趨勢：

患有過敏症和過敏反應的人越來越多，對自我管理藥物的需求不斷增加，這是推動世界各地對腎上腺素自動注射器需求的主要因素之一。此外，關節炎、哮喘、癌症和慢性阻塞性肺病（COPD）的發病率激增，以及老齡化人口的增加，更容易發生過敏反應，都對市場產生了積極的影響。此外，大眾對食物過敏的發生率不斷增加，也促進了市場的成長。除此之外，許多國家的管理機構正在採取計劃，在學校和其他公共場所推廣使用腎上腺素自動注射器。這一點，加上對腎上腺素自動注射器的認識不斷提高，正在促進市場成長。此外，主要參與者正在推出智慧腎上腺素自動注射器，這些注射器整合了先進的技術，包括藍牙連接、感測器和機器學習，使其更加方便、方便用戶使用和有效。領先的企業還在推出可與智慧手機或其他設備連接的行動應用程式，允許遠程監控、追踪使用情況和到期日，並確保病人不超過建議劑量。這些進步還能幫助預測過敏反應的可能性，並提供個性化的治療建議。再加上在腎上腺素自動注射器中加入自動體外除顫器（AED），以提供一個全面的應急系統，正在為市場創造一個積極的前景。

本報告中回答的關鍵問題：

  • 迄今為止，全球腎上腺素自動注射器市場表現如何，未來幾年將如何表現？
  • 全球腎上腺素自動注射器市場的驅動因素、限制因素和機會是什麼？
  • 每個驅動因素、限制因素和機會對全球腎上腺素自動注射器市場的影響是什麼？
  • 主要的區域市場是什麼？
  • 哪些國家代表了最有吸引力的腎上腺素自動注射器市場？
  • 基於劑量的市場細分是什麼？
  • 腎上腺素自動注射器市場中最有吸引力的劑量是什麼？
  • 基於應用的市場細分是什麼？
  • 腎上腺素自動注射器市場中最有吸引力的應用是哪個？
  • 基於終端用戶的市場細分是什麼？
  • 哪個是腎上腺素自動注射器市場中最有吸引力的終端用戶？
  • 全球腎上腺素自動注射器市場的競爭結構是什麼？
  • 誰是全球腎上腺素自動注射器市場的主要參與者/公司？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球腎上腺素自動注射器市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按劑量分類的市場

  • 0.15毫克腎上腺素自動注射器
    • 市場趨勢
    • 市場預測
  • 0.3毫克腎上腺素自動注射器
    • 市場趨勢
    • 市場預測
  • 0.5毫克腎上腺素自動注射器
    • 市場趨勢
    • 市場預測

第7章：按應用分類的市場

  • 6歲以下
    • 市場趨勢
    • 市場預測
  • 6至12年
    • 市場趨勢
    • 市場預測
  • 12年以上
    • 市場趨勢
    • 市場預測

第8章：按終端用戶分類的市場

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：驅動因素、限制因素和機會

  • 概述
  • 驅動因素
  • 限制因素
  • 機會

第十一章：價值鏈分析

第十二章：波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章：價格分析

第十四章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • Adamis Pharmaceuticals Corporation
    • Amneal Pharmaceuticals Inc.
    • Antares Pharma Inc
    • Bausch Health
    • Kaleo Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.

請注意，這只代表部分公司的名單，完整的名單已在報告中提供。

Product Code: SR112023A7369

Market Overview:

The global epinephrine autoinjector market size reached US$ 2.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.40% during 2023-2028. The increasing number of individuals with allergies, rising need for self-administrating medicines, and the launch of smart epinephrine autoinjector represent some of the key factors driving the market.

Epinephrine autoinjector is a medical device used to administer single dose epinephrine easily for treating severe allergic reactions caused by stings, bug bites, or drugs. It is designed to deliver the medication into the thigh muscle of an individual and works by constricting blood vessels and dilating the airways to minimize the symptoms of an allergic reaction. It is small and easy to carry and can be administered by individuals or healthcare professionals. At present, leading manufacturers are introducing epinephrine autoinjector with multiple doses of medications and adjustable dosages that enable the user to adjust the dose according to the severity of the allergic reaction and improve the effectiveness of the treatment. They are also incorporating audio and visual instructions to make it easier for individuals to use them in an emergency. 

Epinephrine Autoinjector Market Trends:

The increasing number of individuals with allergies and allergic reactions and the rising need for self-administrating medicines represent one of the major factors driving the demand for epinephrine autoinjectors around the world. Moreover, the surging prevalence of arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD) and the growing aging population, which is more prone to develop allergic reactions, is influencing the market positively. In addition, the increasing incidence of food allergies among the masses is bolstering the growth of the market. Apart from this, governing agencies of numerous countries are undertaking initiatives to promote the use of epinephrine autoinjectors in schools and other public spaces. This, coupled with the rising awareness about epinephrine autoinjectors, is contributing to the market growth. Furthermore, key players are introducing smart epinephrine autoinjectors that are integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning, to make them more convenient, user friendly, and effective. Leading players are also launching mobile applications that can be connected to smartphones or other devices, allowing remote monitoring, tracking of usage and expiration dates, and ensuring the patient does not exceed the recommended dosage. These advancements can also help predict the likelihood of an allergic reaction and provide personalized recommendations for treatment. This, along with the incorporation of an automated external defibrillator (AED) in epinephrine autoinjectors to offer a comprehensive emergency response system, is creating a positive outlook for the market.  

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global epinephrine autoinjector market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on dosage, application, and end user.

Dosage Insights:

  • 0.15mg Epinephrine Autoinjector
  • 0.3mg Epinephrine Autoinjector
  • 0.5mg Epinephrine Autoinjector

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the dosage. This includes 0.15mg epinephrine autoinjector, 0.3mg epinephrine autoinjector, and 0.5mg epinephrine autoinjector. According to the report, 0.3mg epinephrine autoinjector represented the largest segment.

Application Insights:

  • Under 6 Years
  • 6 to 12 Years
  • Over 12 Years

A detailed breakup and analysis of the epinephrine autoinjector market based on the application has also been provided in the report. This includes under 6 years, 6 to 12 years, and over 12 years. According to the report, 6 to 12 years represented the largest segment.

End User Insights:

  • Hospitals
  • Clinics
  • Others

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the end user. This includes hospitals, clinics, and others. According to the report, hospitals represented the largest segment.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for epinephrine autoinjectors. Some of the factors driving the North America epinephrine autoinjector market included the rising prevalence of allergies, increasing awareness about anaphylaxis, and the availability of cost-effective generic versions of autoinjectors.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global epinephrine autoinjector market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global epinephrine autoinjector market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global epinephrine autoinjector market?
  • What is the impact of each driver, restraint, and opportunity on the global epinephrine autoinjector market?
  • What are the key regional markets?
  • Which countries represent the most attractive epinephrine autoinjector markets?
  • What is the breakup of the market based on the dosage?
  • Which is the most attractive dosage in the epinephrine autoinjector market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the epinephrine autoinjector market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the epinephrine autoinjector market?
  • What is the competitive structure of the global epinephrine autoinjector market?
  • Who are the key players/companies in the global epinephrine autoinjector market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Epinephrine Autoinjector Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Dosage

  • 6.1 0.15mg Epinephrine Autoinjector
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 0.3mg Epinephrine Autoinjector
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 0.5mg Epinephrine Autoinjector
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Under 6 Years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 6 to 12 Years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Over 12 Years
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adamis Pharmaceuticals Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Amneal Pharmaceuticals Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Antares Pharma Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Bausch Health
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Kaleo Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Teva Pharmaceutical Industries Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Viatris Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Epinephrine Autoinjector Market: Major Drivers and Challenges
  • Figure 2: Global: Epinephrine Autoinjector Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Epinephrine Autoinjector Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Epinephrine Autoinjector Market: Breakup by Dosage (in %), 2022
  • Figure 5: Global: Epinephrine Autoinjector Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Epinephrine Autoinjector Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Epinephrine Autoinjector Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Epinephrine Autoinjector (Under 6 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Epinephrine Autoinjector (Under 6 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Epinephrine Autoinjector (6 to 12 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Epinephrine Autoinjector (6 to 12 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Epinephrine Autoinjector (Over 12 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Epinephrine Autoinjector (Over 12 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Epinephrine Autoinjector (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Epinephrine Autoinjector (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Epinephrine Autoinjector (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Epinephrine Autoinjector (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Epinephrine Autoinjector (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Epinephrine Autoinjector (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Epinephrine Autoinjector Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Epinephrine Autoinjector Industry: Drivers, Restraints, and Opportunities
  • Figure 76: Global: Epinephrine Autoinjector Industry: Value Chain Analysis
  • Figure 77: Global: Epinephrine Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Epinephrine Autoinjector Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Epinephrine Autoinjector Market Forecast: Breakup by Dosage (in Million US$), 2023-2028
  • Table 3: Global: Epinephrine Autoinjector Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Epinephrine Autoinjector Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Epinephrine Autoinjector Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Epinephrine Autoinjector Market: Competitive Structure
  • Table 7: Global: Epinephrine Autoinjector Market: Key Players